| Metric | Value (₹ Cr) | vs Q2 FY25 |
|---|---|---|
| Revenue | 316.46 | 0.6% |
| Total Income | 320.79 | 0.1% |
| Expenditure | 275.20 | 0.6% |
| PBT | 45.59 | 2.6% |
| Net Profit | 34.20 | 2.3% |
| OPM | 11.36% | 1.04pp |
| NPM | 10.66% | 0.26pp |
| EPS | 5.97 | 2.5% |
Innova Captab Reports 4.6% YoY Revenue Growth and 36.3% PAT Growth in Q3 FY25
06 Feb 2025 · 6 Feb 2025, 12:58 am
Summary
Innova Captab Limited, a leading integrated pharmaceutical company, announced its financial results for the quarter and nine months ending December 31, 2024. The company reported a YoY revenue growth of 4.6% and a PAT growth of 36.3% in Q3 FY25. The key highlights include the successful launch of operations at the new Kathua, Jammu facility.
Key Highlights
- 1
Revenue from Operations at 316.5 crores in Q3 FY25, registering growth of 4.6%
- 2
Profit After Tax (PAT) at 34.2 crores in Q3 FY25, demonstrating a surge of 36.3%
- 3
13.5% YoY growth in revenue from operations for 9M FY25
- 4
50.5% YoY growth in PAT for 9M FY25
- 5
Successful launch of operations at the new Kathua, Jammu facility
Management Comments
Mr. Vinay Lohariwala
Managing Director — Innova Captab Limited
We are delighted to report a healthy performance in Q3 and 9M FY25, driven by robust resilience in our core business operations and strategic advancements. Our revenue from operations registered YoY growth of 4.6% in Q3 FY25 and of 13.5% in 9M FY25. PAT demonstrated strong surge of 36.3% in Q3 FY25 and of 50.5% in 9M FY25. Key highlight of the quarter was the successful launch of operations at our new Kathua, Jammu facility, where we commenced commercial production on January 14, 2025. This milestone represents a pivotal moment in our growth trajectory, bolstering both our production capacity and our ability to meet the evolving demands of our customers. This expansion is a cornerstone of our long-term strategic vision, reinforcing our market position and laying the foundation for sustained, profitable growth.
Informational and educational content only. Not investment advice.